NEW YORK (GenomeWeb) – Swiss bioinformatics company Saphetor announced today that it has signed multiple service agreements with University College London (UCL) for its precision medicine platform.

Saphetor's software-as-a-service platform automatically annotates and classifies genetic variants from next-generation sequencing data and is designed to help clinicians diagnose disease and select the most effective therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.